INDIVIDUAL ARTICLE: Real-World Study of Topical Corticosteroid-Associated Adverse Events in the FDA Adverse Event Reporting System
Journal of Drugs in Dermatology · 01.11.2026 · 25 (11) · 10425s21-10425s30
DOI: 10.36849/jdd.10425 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Drugs in Dermatology, online erschienen am 01.10.2026. Verfasst von Adam J Friedman und 10 weiteren Autor:innen. Hauptthemen laut MEDLINE: Adverse Drug Reaction Reporting Systems, Adrenal Cortex Hormones.
Themen: Patientensicherheit
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Friedman, A. J., Derrick, K. M., Martin, G., Siegfried, E. C., Seal, M. S., Jaworski, J. C., Stephenson, B., Mikkili, R., Higham, R. C., Hanna, D., & Golant, A. K. (2026). INDIVIDUAL ARTICLE: Real-World Study of Topical Corticosteroid-Associated Adverse Events in the FDA Adverse Event Reporting System. Journal of Drugs in Dermatology, 25(11), 10425s21-10425s30. https://doi.org/10.36849/jdd.10425
Vancouver
Friedman AJ, Derrick KM, Martin G, Siegfried EC, Seal MS, Jaworski JC, et al. INDIVIDUAL ARTICLE: Real-World Study of Topical Corticosteroid-Associated Adverse Events in the FDA Adverse Event Reporting System. Journal of Drugs in Dermatology. 2026;25(11):10425s21-10425s30. doi:10.36849/jdd.10425
BibTeX
@article{Friedman2026,
author = {Friedman, Adam J and Derrick, Kristina M and Martin, George and Siegfried, Elaine C and Seal, Melissa S and Jaworski, Jennifer C and Stephenson, Brett and Mikkili, Raja and Higham, Robert C and Hanna, Diane and Golant, Alexandra K},
title = {INDIVIDUAL ARTICLE: Real-World Study of Topical Corticosteroid-Associated Adverse Events in the FDA Adverse Event Reporting System},
journal = {Journal of Drugs in Dermatology},
year = {2026},
volume = {25},
number = {11},
pages = {10425s21--10425s30},
doi = {10.36849/jdd.10425}
}
EUVIMED